Aperam S.A. (OTCMKTS:APEMY – Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,700 shares, a decline of 68.5% from the February 28th total of 5,400 shares. Based on an average trading volume of 1,600 shares, the days-to-cover ratio is presently 1.1 days. Currently, 0.0% of the company’s shares are sold short.
Aperam Stock Performance
OTCMKTS:APEMY opened at $33.45 on Friday. The company has a quick ratio of 0.56, a current ratio of 2.82 and a debt-to-equity ratio of 0.15. Aperam has a twelve month low of $25.18 and a twelve month high of $35.75. The stock has a market cap of $2.45 billion, a P/E ratio of 9.67 and a beta of 1.65. The firm’s fifty day simple moving average is $30.51 and its 200 day simple moving average is $28.88.
Aperam (OTCMKTS:APEMY – Get Free Report) last issued its quarterly earnings results on Friday, February 7th. The company reported $0.18 earnings per share for the quarter. Aperam had a return on equity of 2.02% and a net margin of 3.73%. As a group, research analysts predict that Aperam will post 2.84 EPS for the current year.
Aperam Increases Dividend
About Aperam
Aperam SA, together with its subsidiaries, produces and sells stainless and specialty steel products worldwide. It operates through four segments: Stainless & Electrical Steel; Services & Solutions; Alloys & Specialties; and Recycling & Renewables. The company offers a range of stainless steel products, including grain oriented and non-grain oriented electrical steel products, and specialty alloys.
See Also
- Five stocks we like better than Aperam
- Growth Stocks: What They Are, What They Are Not
- MarketBeat Week in Review – 03/24 – 03/28
- How to Read Stock Charts for Beginners
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Industrial Products Stocks Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Aperam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aperam and related companies with MarketBeat.com's FREE daily email newsletter.